Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of the National Medical Association

• Publication date

  1985-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 2414458PMCID PMC2571176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung cancer: Current concepts and prospects

  1983cited by this paper
• Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes.

  1983cited by this paper
• Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer.

  1983cited by this paper
• Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung.

  1983cited by this paper
• Is immediate radiation therapy indicated for patients with unresectable non-small cell lung cancer? No.

  1983cited by this paper
• Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection.

  1982cited by this paper
• Vindesine in bronchogenic carcinoma: a phase II trial.

  1982cited by this paper
• Efficacy study of intensive cis‐platin therapy in advanced non‐small cell bronchogenic carcinoma

  1982cited by this paper
• Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.

  1982cited by this paper
• Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)

  1982cited by this paper
• Phase II trial of VP-16-213 in non-small-cell lung cancer.

  1982cited by this paper
• Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.

  1982cited by this paper
• Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.

  1982cited by this paper
• Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer.

  1981cited by this paper
• Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

  1981cited by this paper
• Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.

  1981cited by this paper
• Detection of true pathologic stage I lung cancer in a screening program and the effect on survival

  1981cited by this paper
• Survival of patients surgically treated for stage I lung cancer.

  1981cited by this paper
• Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.

  1981cited by this paper
• Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.

  1981cited by this paper
• 5‐Fluorouracil, adriamycin, and mitomycin‐C (Hi‐FAM) chemotherapy for adenocarcinoma of the lung

  1981cited by this paper
• Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.

  1981cited by this paper
• Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.

  1981cited by this paper
• Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.

  1981cited by this paper
• Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.

  1981cited by this paper
• High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).

  1980cited by this paper
• Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMi).

  1980cited by this paper
• Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.

  1979cited by this paper
• cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.

  1979cited by this paper
• 5‐fluorouracil, adriamycin, and mitomycin‐C (FAM) chemotherapy for adenocarcinoma of the lung

  1979cited by this paper
• cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.

  1979cited by this paper
• "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.

  1979cited by this paper
• Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.

  1979cited by this paper
• MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung. Low response rate in a cooperative group study

  1979cited by this paper
• MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer

  1979cited by this paper
• Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.

  1979cited by this paper
• cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.

  1978cited by this paper
• VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.

  1978cited by this paper
• An aggressive approach to marginally resectable lung cancer

  1978cited by this paper
• Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5‐fluorouracil, and prednisone in solid tumors

  1977cited by this paper
• Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.

  1977cited by this paper
• Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

  1977cited by this paper
• Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study.

  1977cited by this paper
• Therapy of advanced squamous carcinoma of the lung. Cyclophosphamide versus “COMB”

  1977cited by this paper
• Regional immunotherapy of lung cancer with intrapleural B.C.G.

  1976cited by this paper
• Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

  1976cited by this paper
• Bacon (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients

  1976cited by this paper
• Evaluation of methotrexate in the treatment of bronchogenic carcinoma

  1975cited by this paper
• Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial. A collaborative study

  1975cited by this paper
• COMB (cyclophosphamide, oncovin, methyl‐ccnu, and bleomycin): A four‐drug combination in solid tumors

  1975cited by this paper
• The james ewing lecture. Looking at lung cancer

  1973cited by this paper
• Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma.

  1970cited by this paper
• The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

  1968cited by this paper
• CONTROLLED STUDIES OF THE THERAPY OF NONRESECTABLE CANCER OF THE LUNG. I. METHODOLOGY.

  1965cited by this paper
• Carcinoma of the lung with five-year survival; a study of 3,000 cases.

  1956cited by this paper

• Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer

  2015cites this paper
• In vivo study of vinorelbine associations with cisplatin, 5-fluorouracil or actinomycin D relative to a non-small-cell lung carcinoma (NSCLCN6-L16).

  1993cites this paper
• Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).

  1989cites this paper